B. Nalpas et al., A COMPARATIVE-STUDY BETWEEN CARBOHYDRATE-DEFICIENT TRANSFERRIN AND GAMMA-GLUTAMYL-TRANSFERASE FOR THE DIAGNOSIS OF EXCESSIVE DRINKING IN A LIVER UNIT, Journal of hepatology, 27(6), 1997, pp. 1003-1008
Aim: To compare the efficacy of carbohydrate-deficient transferrin and
gamma-glutamyltransferase for the diagnosis of excessive alcohol inta
ke in patients admitted in a liver unit. Methods: The 336 patients mer
e divided into three groups of alcoholics: 57 patients (31 men, 26 wom
en) with a normal liver, 77 patients (51 men, 26 women) with non-cirrh
otic alcoholic liver disease, and 61 patients (43 men, 18 women) with
alcoholic cirrhosis; and three groups of non-alcoholics: 35 abstainers
(21 men, 14 women), and 58 healthy blood donors (26 men, 32 women), a
nd 58 patients (32 men, 26 women) who had a non-alcoholic liver diseas
e, Carbohydrate-deficient transferrin and gamma-glutamyltransferase we
re measured at admission using commercially available kits. Results: C
arbohydrate-deficient transferrin was more sensitive than gamma-glutam
yltransferase in patients without alcoholic liver disease, in both men
(85 vs 54%) and women (64 vs 36%), Carbohydrate-deficient transferrin
sensitivity decreased slightly but not significantly according to the
severity of the liver disease in men and women, The sensitivity of ga
mma-glutamyltransferase which was low in men and women without alcohol
ic liver disease, improved in groups with moderate or severe alcoholic
liver disease: not less than 80% in men and up to 100% in women, The
specificity of carbohydrate-deficient transferrin in patients with non
-alcoholic liver disease was consistently higher than that of gamma-gl
utamyltransferase (80% vs 60%). Conclusions: In liver units, carbohydr
ate-deficient transferrin can help to identify excessive drinkers with
out liver disease with a higher efficacy than that of gamma-glutamyltr
ansferase; carbohydrate-deficient transferrin can also be used to dist
inguish between alcoholics with moderate liver disease and patients wi
th non-alcoholic liver diseases.